Alessa Therapeutics (“Alessa”), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology for the treatment of early-stag…
SAN CARLOS, Calif.–(BUSINESS WIRE)–Alessa Therapeutics (“Alessa”), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology for the treatment of early-stage prostate cancers, today announced that the U.S. Food a… [2686 chars]
Source: Business Wire | Published: 2026-01-08T19:26:00Z
Credit: Business Wire
